Clinical Trial Update: Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adalimumab in combination with a calcipotriol/betamethasone dipropionate topical treatment for moderate-to-severe chronic plaque psoria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Calcipotriol/betamethasone dipropionate topical (calcipotriol/betamethasone dipropionate)

Snippet

Sponsor: Abbott | Conditions: Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18